AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arjmandi, B. H.
Right arrow Articles by Kukreja, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arjmandi, B. H.
Right arrow Articles by Kukreja, S. C.
Agricola
Right arrow Articles by Arjmandi, B. H.
Right arrow Articles by Kukreja, S. C.

American Journal of Clinical Nutrition, Vol 68, 1364S-1368S, Copyright © 1998 by The American Society for Clinical Nutrition, Inc


ORIGINAL RESEARCH COMMUNICATIONS

Bone-sparing effect of soy protein in ovarian hormone-deficient rats is related to its isoflavone content

BH Arjmandi, R Birnbaum, NV Goyal, MJ Getlinger, S Juma, L Alekel, CM Hasler, ML Drum, BW Hollis and SC Kukreja
Department of Nutritional Sciences, Oklahoma State University, Stillwater 74078-6141, USA. arjmand@okstate.edu

Our previous studies showed that a soy-protein diet prevents ovariectomy-induced bone loss. The purpose of this study was to determine whether isoflavones in soy protein are responsible for this bone-protective effect. Forty-eight 95-d-old Sprague-Dawley rats were divided into 4 groups: sham-operated fed a casein-based diet (SHAM), ovariectomized fed a casein-based diet (OVX+CASEIN), ovariectomized fed soy protein with normal isoflavone content (OVX+SOY), and ovariectomized fed soy protein with reduced isoflavone content (OVX+SOY- ). The OVX+SOY group had significantly greater femoral bone density (in g/cm3 bone vol) than the OVX+CASEIN group, whereas OVX+SOY- was similar to OVX+CASEIN (mean +/- SD; SHAM, 1.522 +/- 0.041; OVX+CASEIN, 1.449 +/- 0.044; OVX+SOY, 1.497 +/- 0.030; OVX+SOY-, 1.452 +/- 0.030). Ovariectomy resulted in greater bone turnover as indicated by higher serum alkaline phosphatase activity, serum insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations, and urinary hydroxyproline. These increases were not affected by soy with either normal or reduced isoflavone content. Similarly, histomorphometry revealed a greater bone formation rate with ovariectomy, and this was not altered by the soy diets. The findings of this study suggest that isoflavones in soy protein are responsible for its bone-sparing effects. Further studies to evaluate the mechanism of action of isoflavones on bone are warranted.


This article has been cited by other articles:


Home page
Evid Based Complement Alternat MedHome page
C. D. Johnson, E. A. Lucas, S. Hooshmand, S. Campbell, M. P. Akhter, and B. H. Arjmandi
Addition of Fructooligosaccharides and Dried Plum to Soy-based Diets Reverses Bone Loss in the Ovariectomized Rat
Evid. Based Complement. Altern. Med., July 30, 2008; (2008) nen050v1.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
C. J Lees, J. R Kaplan, H. Chen, C. P Jerome, T. C Register, and A. A Franke
Bone mass and soy isoflavones in socially housed, premenopausal macaques
Am. J. Clinical Nutrition, July 1, 2007; 86(1): 245 - 250.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. Fujioka, M. Uehara, J. Wu, H. Adlercreutz, K. Suzuki, K. Kanazawa, K. Takeda, K. Yamada, and Y. Ishimi
Equol, a Metabolite of Daidzein, Inhibits Bone Loss in Ovariectomized Mice
J. Nutr., October 1, 2004; 134(10): 2623 - 2627.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
K. D. Setchell and E. Lydeking-Olsen
Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies
Am. J. Clinical Nutrition, September 1, 2003; 78(3): 593S - 609.
[Abstract] [Full Text] [PDF]


Home page
Integr Cancer TherHome page
C. E. Piersen
Phytoestrogens in Botanical Dietary Supplements: Implications for Cancer
Integr Cancer Ther, June 1, 2003; 2(2): 120 - 138.
[Abstract] [PDF]


Home page
J Am Acad Orthop SurgHome page
W. Cabot
Phytoestrogens
J. Am. Acad. Ortho. Surg., May 1, 2003; 11(3): 153 - 156.
[Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
J. J. B. Anderson, X. Chen, A. Boass, M. Symons, M. Kohlmeier, J. B. Renner, and S. C. Garner
Soy Isoflavones: No Effects on Bone Mineral Content and Bone Mineral Density in Healthy, Menstruating Young Adult Women after One Year
J. Am. Coll. Nutr., October 1, 2002; 21(5): 388 - 393.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
D. A. Khalil, E. A. Lucas, S. Juma, B. J. Smith, M. E. Payton, and B. H. Arjmandi
Soy Protein Supplementation Increases Serum Insulin-Like Growth Factor-I in Young and Old Men but Does Not Affect Markers of Bone Metabolism
J. Nutr., September 1, 2002; 132(9): 2605 - 2608.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
V. W Persky, M. E Turyk, L. Wang, S. Freels, R. Chatterton Jr, S. Barnes, J. Erdman Jr, D. W Sepkovic, H L. Bradlow, and S. Potter
Effect of soy protein on endogenous hormones in postmenopausal women
Am. J. Clinical Nutrition, January 1, 2002; 75(1): 145 - 153.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. E. Burdette, J. Liu, D. Lantvit, E. Lim, N. Booth, K. P. L. Bhat, S. Hedayat, R. B. Van Breemen, A. I. Constantinou, J. M. Pezzuto, et al.
Trifolium pratense (Red Clover) Exhibits Estrogenic Effects In Vivo in Ovariectomized Sprague-Dawley Rats
J. Nutr., January 1, 2002; 132(1): 27 - 30.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. Picherit, C. Bennetau-Pelissero, B. Chanteranne, P. Lebecque, M.-J. Davicco, J.-P. Barlet, and V. Coxam
Soybean Isoflavones Dose-Dependently Reduce Bone Turnover but Do Not Reverse Established Osteopenia in Adult Ovariectomized Rats
J. Nutr., March 1, 2001; 131(3): 723 - 728.
[Abstract] [Full Text]


Home page
Am. J. Clin. Nutr.Home page
D L. Alekel, A. S. Germain, C. T Peterson, K. B Hanson, J. W Stewart, and T. Toda
Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women
Am. J. Clinical Nutrition, September 1, 2000; 72(3): 844 - 852.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. Picherit, V. Coxam, C. Bennetau-Pelissero, S. Kati-Coulibaly, M.-J. Davicco, P. Lebecque, and J.-P. Barlet
Daidzein Is More Efficient than Genistein in Preventing Ovariectomy-Induced Bone Loss in Rats
J. Nutr., July 1, 2000; 130(7): 1675 - 1681.
[Abstract] [Full Text]


Home page
J. Am. Coll. Nutr.Home page
J. Z. Ilich and J. E. Kerstetter
Nutrition in Bone Health Revisited: A Story Beyond Calcium
J. Am. Coll. Nutr., June 1, 2000; 19(6): 715 - 737.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
G. L. Burke, M. Z. Vitolins, and D. Bland
Soybean Isoflavones as an Alternative to Traditional Hormone Replacement Therapy: Are We There Yet?
J. Nutr., March 1, 2000; 130(3): 664 - 664.
[Full Text]


Home page
Am. J. Clin. Nutr.Home page
M. J Messina
Legumes and soybeans: overview of their nutritional profiles and health effects
Am. J. Clinical Nutrition, September 1, 1999; 70(3): 439S - 450.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by The American Society for Nutrition